dicholoroacetate metabolism glutathione transferase Targeting Glucose of Cancer Cells with Dichloroacetate to Radiosensitize High-Grade Gliomas Clinical physiology and pharmacology of

Compounded medications are not FDA-approved, and FDA does not evaluate compounded medications for safety, effectiveness, or quality before they are marketed

cancer treatment should always be managed by board-certified oncologists and appropriate specialists.

Supporting evidence for the prefrontal hypodopaminergia came from PET (positron emission tomography) studies showing reduced cerebral blood flow in frontal cortex, which was directly correlated with low cerebrospinal fluid (CSF) DA metabolite levels in schizophrenia patients

Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects